These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16838555)

  • 1. [Present insights in the cerebral small vessel disease physiopathology: the role of C-reactive protein].
    Di Napoli M; Papa F
    Recenti Prog Med; 2006 May; 97(5):246-56. PubMed ID: 16838555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study.
    van Dijk EJ; Prins ND; Vermeer SE; Vrooman HA; Hofman A; Koudstaal PJ; Breteler MM
    Circulation; 2005 Aug; 112(6):900-5. PubMed ID: 16061741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology?
    Di Napoli M; Papa F
    Circulation; 2005 Aug; 112(6):781-5. PubMed ID: 16087807
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory markers and conventional atherosclerotic risk factors in acute ischemic stroke: comparative study between vascular disease subtypes.
    Suwanwela NC; Chutinet A; Phanthumchinda K
    J Med Assoc Thai; 2006 Dec; 89(12):2021-7. PubMed ID: 17214052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral vessel disease and inflammatory process].
    Kitagawa K
    Brain Nerve; 2009 Sep; 61(9):1061-8. PubMed ID: 19803405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis.
    Labarrere CA; Zaloga GP
    Am J Med; 2004 Oct; 117(7):499-507. PubMed ID: 15464707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?
    Boos CJ; Lip GY
    J Hum Hypertens; 2005 Jul; 19(7):511-3. PubMed ID: 15905894
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of inflammation for heart disease risk cannot be determined by correlations between C-reactive protein and risk factors.
    Engström G
    Arch Intern Med; 2006 May; 166(9):1040; author reply 1040-1. PubMed ID: 16682580
    [No Abstract]   [Full Text] [Related]  

  • 10. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein measurement in the patient with vascular disease.
    Widener JM
    J Vasc Nurs; 2007 Sep; 25(3):51-4. PubMed ID: 17723910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age related macular degeneration and C-reactive protein].
    Stefan C; Dumitrica DM; Tebeanu E; Sapundgieva A; Dragomir L; Cristea I
    Oftalmologia; 2008; 52(3):73-6. PubMed ID: 19149122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function.
    Pizzi C; Manzoli L; Mancini S; Costa GM
    Eur Heart J; 2008 May; 29(9):1110-7. PubMed ID: 18400765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nuts on inflammation.
    Salas-Salvadó J; Casas-Agustench P; Murphy MM; López-Uriarte P; Bulló M
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():333-6. PubMed ID: 18296371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of educational level to inflammation-sensitive biomarker level.
    Steinvil A; Shirom A; Melamed S; Toker S; Justo D; Saar N; Shapira I; Berliner S; Rogowski O
    Am J Cardiol; 2008 Oct; 102(8):1034-9. PubMed ID: 18929705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers in stable atherosclerosis.
    Kinlay S; Egido J
    Am J Cardiol; 2006 Dec; 98(11A):2P-8P. PubMed ID: 17126676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.